Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Rosemann

Showing results (751-760 of 762) with videos related to

Pageof 77
Sort By:
The Lancet. Haematology|July 2, 2022
Enoxaparin for primary thromboprophylaxis in symptomatic outpatients with COVID-19 (OVID): a randomised, open-label, parallel-group, multicentre, phase 3 trialStefano Barco, Davide Voci, Ulrike Held, et al.
Epidemiology (Cambridge, Mass.)|November 26, 2015
Physician's Prescribing Preference as an Instrumental Variable: Exploring Assumptions Using Survey DataAnna G C Boef, Saskia le Cessie, Olaf M Dekkers, et al.
Journal of Functional Morphology and Kinesiology|June 2, 2021
Evaluation of Strength and Muscle Activation Indicators in Sticking Point Region of National-Level Paralympic Powerlifting AthletesFelipe J Aidar, Filipe Manuel Clemente, Dihogo Gama de Matos, et al.
Thrombosis Research|November 17, 2022
Enoxaparin for outpatients with COVID-19: 90-day results from the randomised, open-label, parallel-group, multinational, phase III OVID trialDavide Voci, Andrea Götschi, Ulrike Held, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|January 28, 2015
International variation in GP treatment strategies for subclinical hypothyroidism in older adults: a case-based surveyWendy P J den Elzen, Anne A Lefèbre-van de Fliert, Vanessa Virgini, et al.
Thrombosis Research|August 25, 2023
Enoxaparin for symptomatic COVID-19 managed in the ambulatory setting: An individual patient level analysis of the OVID and ETHIC trialsStefano Barco, Saverio Virdone, Andrea Götschi, et al.
BMC Geriatrics|April 22, 2017
Variation in GP decisions on antihypertensive treatment in oldest-old and frail individuals across 29 countriesSven Streit, Marjolein Verschoor, Nicolas Rodondi, et al.
Scandinavian Journal of Primary Health Care|January 26, 2018
Burden of cardiovascular disease across 29 countries and GPs' decision to treat hypertension in oldest-oldSven Streit, Jacobijn Gussekloo, Robert A Burman, et al.
Journal of General Internal Medicine|January 18, 2019
Patient Characteristics and General Practitioners' Advice to Stop Statins in Oldest-Old Patients: a Survey Study Across 30 CountriesMilly A van der Ploeg, Sven Streit, Wilco P Achterberg, et al.
Sports Medicine (Auckland, N.Z.)|June 15, 2026
Toward Precision Cardiac Rehabilitation: Current Limitations and Future Opportunities of Omics and Artificial IntelligenceAmine Ghram, Javier Loureiro Diaz, Preeti Raghavan, et al.
Pageof 77

Showing results (751-760 of 762) with videos related to

Sort By:
Pageof 77
The Lancet. Haematology|July 2, 2022
Enoxaparin for primary thromboprophylaxis in symptomatic outpatients with COVID-19 (OVID): a randomised, open-label, parallel-group, multicentre, phase 3 trialStefano Barco, Davide Voci, Ulrike Held, et al.
Epidemiology (Cambridge, Mass.)|November 26, 2015
Physician's Prescribing Preference as an Instrumental Variable: Exploring Assumptions Using Survey DataAnna G C Boef, Saskia le Cessie, Olaf M Dekkers, et al.
Journal of Functional Morphology and Kinesiology|June 2, 2021
Evaluation of Strength and Muscle Activation Indicators in Sticking Point Region of National-Level Paralympic Powerlifting AthletesFelipe J Aidar, Filipe Manuel Clemente, Dihogo Gama de Matos, et al.
Thrombosis Research|November 17, 2022
Enoxaparin for outpatients with COVID-19: 90-day results from the randomised, open-label, parallel-group, multinational, phase III OVID trialDavide Voci, Andrea Götschi, Ulrike Held, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|January 28, 2015
International variation in GP treatment strategies for subclinical hypothyroidism in older adults: a case-based surveyWendy P J den Elzen, Anne A Lefèbre-van de Fliert, Vanessa Virgini, et al.
Thrombosis Research|August 25, 2023
Enoxaparin for symptomatic COVID-19 managed in the ambulatory setting: An individual patient level analysis of the OVID and ETHIC trialsStefano Barco, Saverio Virdone, Andrea Götschi, et al.
BMC Geriatrics|April 22, 2017
Variation in GP decisions on antihypertensive treatment in oldest-old and frail individuals across 29 countriesSven Streit, Marjolein Verschoor, Nicolas Rodondi, et al.
Scandinavian Journal of Primary Health Care|January 26, 2018
Burden of cardiovascular disease across 29 countries and GPs' decision to treat hypertension in oldest-oldSven Streit, Jacobijn Gussekloo, Robert A Burman, et al.
Journal of General Internal Medicine|January 18, 2019
Patient Characteristics and General Practitioners' Advice to Stop Statins in Oldest-Old Patients: a Survey Study Across 30 CountriesMilly A van der Ploeg, Sven Streit, Wilco P Achterberg, et al.
Sports Medicine (Auckland, N.Z.)|June 15, 2026
Toward Precision Cardiac Rehabilitation: Current Limitations and Future Opportunities of Omics and Artificial IntelligenceAmine Ghram, Javier Loureiro Diaz, Preeti Raghavan, et al.
Pageof 77